Foghorn Therapeutics Inc (NASDAQ: FHTX) is 29.87% higher on its value in year-to-date trading and has touched a low of $3.86 and a high of $10.25 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The FHTX stock was last observed hovering at around $6.16 in the last trading session, with the day’s loss setting it -0.03%.
Currently trading at $6.13, the stock is 33.17% and 22.57% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.18 million and changing -0.49% at the moment leaves the stock -6.28% off its SMA200. FHTX registered -1.45% loss for a year compared to 6-month loss of 9.46%. The firm has a 50-day simple moving average (SMA 50) of $5.0014 and a 200-day simple moving average (SMA200) of $6.5405.
The stock witnessed a 40.92% gain in the last 1 month and extending the period to 3 months gives it a -30.81%, and is 29.05% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.31% over the week and 10.24% over the month.
Foghorn Therapeutics Inc (FHTX) has around 116 employees, a market worth around $340.89M and $25.52M in sales. Profit margin for the company is -357.53%. Distance from 52-week low is 58.81% and -40.20% from its 52-week high. The company has generated returns on investments over the last 12 months (-4531.69%).
with sales reaching $8.27M over the same period.The EPS is expected to grow by 31.46% this year, but quarterly earnings will post -13.55% year-over-year. Quarterly sales are estimated to grow 43.36% in year-over-year returns.
Foghorn Therapeutics Inc (FHTX) Top Institutional Holders
121.0 institutions hold shares in Foghorn Therapeutics Inc (FHTX), with institutional investors hold 94.46% of the company’s shares. The shares outstanding are 55.59M, and float is at 28.06M with Short Float at 3.27%. Institutions hold 73.08% of the Float.
The top institutional shareholder in the company is FLAGSHIP PIONEERING INC. with over 12.67 million shares valued at $72.88 million. The investor’s holdings represent 24.5716% of the FHTX Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 6.38 million shares valued at $$36.7 million to account for 12.3754 of the shares outstanding. The other top investors are BVF INC/IL which holds 5.3 million shares representing 10.2791% and valued at over $30.49 million, while RAYMOND JAMES & ASSOCIATES holds 5.5114 of the shares totaling 2.34 million with a market value of $13.45 million.
Foghorn Therapeutics Inc (FHTX) Insider Activity
The most recent transaction is an insider sale by Costa Carlos,the company’sChief People Officer. SEC filings show that Costa Carlos sold 35,756 shares of the company’s common stock on Sep 20 ’24 at a price of $10.04 per share for a total of $0.36 million. Following the sale, the insider now owns 0.0 shares.
Foghorn Therapeutics Inc disclosed in a document filed with the SEC on Sep 23 ’24 that Costa Carlos (Chief People Officer) sold a total of 857 shares of the company’s common stock. The trade occurred on Sep 23 ’24 and was made at $10.17 per share for $8716.0. Following the transaction, the insider now directly holds 0.0 shares of the FHTX stock.
Still, SEC filings show that on Sep 18 ’24, Costa Carlos (Chief People Officer) disposed off 11,574 shares at an average price of $10.05 for $0.12 million. The insider now directly holds 0 shares of Foghorn Therapeutics Inc (FHTX).
